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interpreted cautiously. Only a few relatives have been exam- 
ined, and therefore ascertainment of the correct diagnosis by 
history alone is difficult. Increased heritability in PD is sug- 
gested by the occasional occurrence of PD in large kindreds 
and in monozygotic twins [4]. We and others have provided 
evidence that a subgroup of PD patients, particularly those 
with prominent tremor, have a genetic susceptibility for PD 
11, 81. This notion contrasts with the conclusion from the 
twin study, in which increased genetic susceptibility could 
not be demonstrated C71. However, it is possible that the 
patients in the twin study had the postural-instability-gait- 
difficulty variety of PD which, in contrast to the tremor type, 
may not be associated with a genetically increased risk for 
PD. 
According to Dr Lang and his colleagues, the occurrence 
of tremor, but not of PD, in first-degree relatives of PD 
patients is three times that expected. Therefore, it must be 
inferred that the tremor among the relatives is of the familial 
essential type. Thus, the 1.3% incidence of coexisting ET 
and PD is surprisingly low. Also, the 4.4% incidence of ET 
in the dystonic population is much lower than that previously 
reported 123. 
Since the publication of our series, we analyzed the cases 
of additional patients with typical PD and pre-existing ET. 
Among 833 typical PD patients and 281 ET patients, we 
identified 56 with a combination of ET and PD. Thus, 6.7% 
of all PD and 19.9% of all ET patients had the combination 
syndrome. (This compares to the expected prevalence of 
0.41% for ET and 0.35% for PD {4,  61.) The number of 
patients with coexisting ET and PD would be higher if Par- 
kinson’s patients who later developed ET were included. 
While it is difficult to diagnose ET in patients with pre- 
existing PD because of the frequent occurrence of action 
tremor in PD, Parkinson’s patients are just as likely, if not 
more so, to develop ET later in life. 
Finally, because our patients are referred from a large geo- 
graphic area, it is difficult to determine the prevalence rate of 
ET in Houston. This, of course, points to one limitation of 
our study, since our patients may be more unique and per- 
haps do not reflect the clinical and hereditary characteristics 
of the general population. However, by using a matched 
population of PD patients, we have attempted to correct for 
this possible bias. Therefore, our conclusion that some ET 
patients carry an increased risk for PD is valid. The data 
presented by Dr Lang and associates provide additional evi- 
dence that the presence of PD increases the risk for ET. 
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ACTH Therapy for 
Infantile Spasms 
Mark G. Goetting, MD 
Adrenocorticotropic hormone (ACTH) is generally accepted 
as the drug of choice for the treatment of infantile spasms. 
Controversy exists over the dose and duration of treatment. 
Some advocate prolonged therapy at high doses for 10 or 
more months 151. I report a case of fatal Pnetlmogstis cariniz 
pneumonia as a complication of prolonged ACTH therapy. 
When first seen, the patient was a 3%-month-old male 
infant with clinical and radiological signs of tuberous sclero- 
sis, developmental delay, infantile spasms, and hypsarrhyth- 
mia shown on electroencephalogram. H e  was treated with 80 
units of ACTH in gel intramuscularly every other day and 
became seizure-free in 4 days. Two months later his seizures 
recurred. His ACTH was increased to 80 units daily. The 
seizure frequency declined but he developed mucocutaneous 
candidiasis that responded poorly to topical therapy. He  also 
became hypertensive. After 3 months, oral prednisone (1 mg 
per kilogram of body weight per day) was substituted for 
ACTH, with intent of tapering. Clonazepam was used for 
seizure control. Two days later the mother thought he was 
“congested.” The next day he was found dead in his crib. 
Postmortem examination revealed bilateral severe pneu- 
monia. The lung interstitium, including the alveolar and 
bronchiolar walls, was filled with lymphocytes and plasma 
cells. The alveoli were lined by a fibrinous exudate and filled 
with a frothy exudate containing many Pneumogstis organ- 
isms. No other pathogens were isolated. 
Pneumocystis carinii pneumonia is exceedingly rare in im- 
munocompetent children beyond the first 3 months of life. 
Prolonged high-dose corticosteroid use has uniformly caused 
Pneurnocystis pneumonia in rats, but has rarely been associ- 
ated with this infection in humans El, 31. It is believed that 
corticosteroids interfere with cellular immunity [ 11. The pa- 
tient described here had no past or family history of immune 
disease and had no other risk factor for opportunistic infec- 
tion. 
The incidence of infectious complications from ACTH 
use in infancy is related to dose, if not duration 141. Two 
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cases of hospital-acquired Pneumocystis pneumonia during 
ACTH therapy have been reported 141. Both patients were 
treated for 6 weeks and one received 120 units per day. An 
informal survey of over 600 cases revealed no other patient 
with known Pneumocystis pneumonia. However a large ma- 
jority of the patients were treated for less than 6 weeks. In 
experimental animals, 2 to 3 months of corticosteroid admin- 
istration is required for infection to develop. 
This case demonstrates that Pneumocystis pneumonia is a 
potential complication of prolonged ACTH therapy in in- 
fants. Not  enough data exist to assess the risk-benefit ra- 
tio of trimethoprim-sulfamethoxazole prophylaxis during 
ACTH therapy, although this strategy is justified in leuke- 
mia [2]. 
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J. Gillego, MD,' G.  Delgado, MD," T. Tuihn,  MD,? 
and J. A. Villanueva, MD" 
The syndrome of postirradiation flaccid paralysis with amyo- 
trophy of the lower limbs was described by Greenfield and 
Stark in 1948 111. Because of its low incidence, there is little 
in the literature about this complication [l-4, 61. No post- 
mortem or neuromuscular biopsy studies of this rare side 
effect of radiotherapy have been published to our knowl- 
edge. We studied a patient with this syndrome in whom 
neuromuscular biopsy strongly suggested a chronic lesion of 
the spinal motor neuron. 
A 34-year-old man was diagnosed in 1970 as having a 
primary bone lymphoma located in the L3 vertebral body. 
He was treated by cobalt beam (4,600 rads in 23 daily frac- 
tions of 200 rads each). A year later, another lesion was 
discovered in the T10 and T11 vertebrae. Both lesions were 
irradiated (5,000 rads in 20 daily fractions of 250 rads each). 
In 1976 another lesion appeared in the T9 vertebra; a total 
dosage of 5,000 rads in 20 daily fractions of 250 rads each 
Gastrocnemius muscle. ( H 6 E ;  x 50 before 43% reduction.) 
was then given. Thirteen months later he began to notice 
weakness and muscular atrophy in the lower limbs. These 
symptoms progressed slowly over the following three years. 
When we examined the patient in 1982, his condition was 
stable subjectively. Neurological examination revealed a se- 
vere motor deficit, with amyotrophy and fasciculation on 
distal muscles of both lower limbs. Knee reflexes were weak 
and ankle reflexes were absent. Plantar responses were flexor 
and cutaneous abdominal reflexes were normal. Sensation, 
sweating, and sphincter functions were preserved. Serial 
samples of cerebrospinal fluid showed only a raised protein 
content at about 80 mg/dl. Electrophoresis was normal. Anti- 
body titers for poliovirus were negative. Motor and sensory 
conduction velocities and somatosensory-evoked potentials 
were normal. Electromyograms of tibialis anterior, quad- 
riceps femoris, and semimembranous muscles bilaterally 
showed fibrillations, fasciculations, and positive potentials. 
The motor unit potentials had neurogenic characteristics. A 
myelogram done with metrizamide followed by a computed 
tomographic scan showed no intradural, extradural, or retro- 
peritoneal abnormalities. Biopsies of the sural nerve and gas- 
trocnemius muscle were obtained for light and electron mi- 
croscopy examination. The sural nerve was normal. The 
gastrocnemius muscle, however, exhibited atrophy of a great 
number of fasciculi, numerous angular fibers with inversion 
of the enzymatic pattern, and fiber-type grouping (Figure). 
The neurological symptoms and signs of the patient remain 
stable as of the time of this report. 
The evident cause of the neurological syndrome in this 
patient was irradiation of the epiconus and conus medullaris 
of the spinal cord. The total dosage received by these spinal 
cord segments, resulting from the superimposition of the 
radiation fields, was estimated at about 8,000 rads, exceeding 
the maximum tolerable dosage for the spinal cord usually 
allowed [5]. The clinical picture of the patient was character- 
ized by slowly progressive and self-limited motor deficit and 
amyotrophy of the lower limbs, which occurred many 
months after radiotherapy. This syndrome is identical to that 
described by Greenfield and Stark [l]. The absence of a 
sensory, sphincter, or sweating disorder makes a lesion of the 
cauda equina and/or lumbosacral plexi unlikely. The histo- 
pathological findings in the muscle biopsy, together with the 
undamaged sural nerve, are typical of a chronic lesion of the 
anterior horn. This combination of data suggests a selective 
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